FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.78, $0.14 better than the analyst estimate of $0.64. Revenue for the quarter came in at $178.2 million versus the consensus estimate of $163.97 million.
GUIDANCE:
Repligen sees FY2021 EPS of $2.86-$2.91, versus the consensus of $2.68. Repligen sees... More

